SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-23-010995
Filing Date
2023-09-08
Accepted
2023-09-08 16:50:07
Documents
16
Period of Report
2023-09-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT dmk-8k_090623.htm   iXBRL 8-K 26951
2 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION OF ADAMIS PHAR ex3-1.htm EX-3.1 8262
3 AMENDED AND RESTATED BYLAWS OF DMK PHARMACEUTICALS CORPORATION ex3-2.htm EX-3.2 136448
4 PRESS RELEASE DATED SEPTEMBER 7, 2023 ex99-1.htm EX-99.1 13330
8 GRAPHIC ex99-1_img01.jpg GRAPHIC 5180
  Complete submission text file 0001387131-23-010995.txt   412761

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dmk-20230906.xsd EX-101.SCH 3051
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dmk-20230906_lab.xml EX-101.LAB 34916
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dmk-20230906_pre.xml EX-101.PRE 22814
10 EXTRACTED XBRL INSTANCE DOCUMENT dmk-8k_090623_htm.xml XML 3565
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
DMK PHARMACEUTICALS Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 231245877
SIC: 2834 Pharmaceutical Preparations